title: Augmenting NF-κB in poor-risk CLL: A general paradigm for other cancers?
authors.affiliation: Cancer Center at Cold Spring Harbor Laboratory; Feinstein Institute for Medical Research, North Shore-LIJ Health System dtuveson@cshl.edu krai@nshs.edu.
authors.forename: David
authors.initials: D
authors.lastname: Tuveson
authors.affiliation: Cancer Center at Cold Spring Harbor Laboratory; Feinstein Institute for Medical Research, North Shore-LIJ Health System dtuveson@cshl.edu krai@nshs.edu.
authors.forename: Kanti R
authors.initials: KR
authors.lastname: Rai
mesh_terms: D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D051550:I-kappa B Kinase / Q000502:physiology*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism*
chemical_list: D016328:NF-kappa B; D051550:I-kappa B Kinase